The management of carotid in-stent restenosis remains challenging, with several potential management strategies available, but none clearly best.
Bioresorbable vascular scaffolds have proved safe and effective in patients with coronary artery disease, but their use for carotid in-stent restenosis is unprecedented, yet promising.
Bioresorbable vascular scaffolds could become a useful adjunct to the armamentarium of endovascular specialists, including those managing patients with carotid in-stent restenosis, especially if further refinements in sizes and designs are achieved.